In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations
Federica Ferrari(University of Ferrara), Girolamo Calò(University of Padua), Uma Gayathri Kamakolanu(Astraea Therapeutics (United States)), Chiara Ruzza(University of Ferrara), Maria Camilla Cerlesi(University of Ferrara), Nurulain T. Zaveri(Astraea Therapeutics (United States)), Remo Guerrini(University of Ferrara), Davide Malfacini(University of Bonn), Elaine C. Gavioli(University of Ferrara), V. Blair Journigan(Astraea Therapeutics (United States)), Anna Rizzi(University of Ferrara), Michael E. Meyer(Astraea Therapeutics (United States)), Laila Asth(Universidade Federal do Rio Grande do Norte), Willma E. Polgar(SRI International), Dennis Yasuda(Astraea Therapeutics (United States))
Cited by 21
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
|Pharmacological Reviews|2016|290